Table 1.
Results of different treatment modalities in localized squamous cell anal cancer
Protocol | CR | CFS | OS | DFS | |
A | RT | 54%[29] | 32% lower colostomy-free rate than C[28] | 14% higher death rate than C[27] | 12.9% higher death and relapse rates at 5 yr than C[27] |
B | RT + 5-FU | NA | 71%[29] | No significant difference from C | 51%[29] |
C | RT + 5-FU + Mitomycin | 80%[29]89.6% at 26 wk[34] | 59%[28] | 78.3% at 5 yr[32,33] | 67.8%[29,30]to 73%[29] |
D | RT + 5-FU + Cisplatin | 90.5% at 26 wk[34] | NA | 70.7% at 5 yr[31,32] | 57.8%[31,32] |
NA: Not availiable; RT: Radiation therapy; 5-FU: 5-Fluorouracil; CR: Complete response; CFS: Colostomy-free survival; OS: Overall survival; DFS: Disease free survival.